Literature DB >> 29663579

Analyzing medical costs with time-dependent treatment: The nested g-formula.

Andrew Spieker1, Jason Roy1, Nandita Mitra1.   

Abstract

As medical expenses continue to rise, methods to properly analyze cost outcomes are becoming of increasing relevance when seeking to compare average costs across treatments. Inverse probability weighted regression models have been developed to address the challenge of cost censoring in order to identify intent-to-treat effects (i.e., to compare mean costs between groups on the basis of their initial treatment assignment, irrespective of any subsequent changes to their treatment status). In this paper, we describe a nested g-computation procedure that can be used to compare mean costs between two or more time-varying treatment regimes. We highlight the relative advantages and limitations of this approach when compared with existing regression-based models. We illustrate the utility of this approach as a means to inform public policy by applying it to a simulated data example motivated by costs associated with cancer treatments. Simulations confirm that inference regarding intent-to-treat effects versus the joint causal effects estimated by the nested g-formula can lead to markedly different conclusions regarding differential costs. Therefore, it is essential to prespecify the desired target of inference when choosing between these two frameworks. The nested g-formula should be considered as a useful, complementary tool to existing methods when analyzing cost outcomes.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; confounding; g-computation; observational studies; time-varying treatment

Mesh:

Year:  2018        PMID: 29663579      PMCID: PMC8218600          DOI: 10.1002/hec.3651

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  Regression analysis of incomplete medical cost data.

Authors:  D Y Lin
Journal:  Stat Med       Date:  2003-04-15       Impact factor: 2.373

2.  Linear regression analysis of censored medical costs.

Authors:  D Y Lin
Journal:  Biostatistics       Date:  2000-03       Impact factor: 5.899

3.  The rise in health care spending and what to do about it.

Authors:  Kenneth E Thorpe
Journal:  Health Aff (Millwood)       Date:  2005 Nov-Dec       Impact factor: 6.301

4.  Methods for dealing with time-dependent confounding.

Authors:  R M Daniel; S N Cousens; B L De Stavola; M G Kenward; J A C Sterne
Journal:  Stat Med       Date:  2012-12-03       Impact factor: 2.373

5.  Nested g-computation: A causal approach to analysis of censored medical costs in the presence of time-varying treatment.

Authors:  Jason A Roy; Nandita Mitra; Andrew J Spieker; Emily M Ko
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2020-08-25       Impact factor: 1.864

6.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

7.  Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.

Authors:  Jiaqi Li; Elizabeth Handorf; Justin Bekelman; Nandita Mitra
Journal:  Stat Med       Date:  2015-12-17       Impact factor: 2.373

8.  The impact of CHIP premium increases on insurance outcomes among CHIP eligible children.

Authors:  Silviya Nikolova; Sally Stearns
Journal:  BMC Health Serv Res       Date:  2014-03-03       Impact factor: 2.655

  8 in total
  2 in total

1.  Net benefit separation and the determination curve: A probabilistic framework for cost-effectiveness estimation.

Authors:  Andrew J Spieker; Nicholas Illenberger; Jason A Roy; Nandita Mitra
Journal:  Stat Methods Med Res       Date:  2021-04-07       Impact factor: 3.021

2.  Nested g-computation: A causal approach to analysis of censored medical costs in the presence of time-varying treatment.

Authors:  Jason A Roy; Nandita Mitra; Andrew J Spieker; Emily M Ko
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2020-08-25       Impact factor: 1.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.